BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
502 results:

  • 1. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
    Lu W; Wang Q; Liu L; Luo W
    Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
    Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
    BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
    Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
    Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
    Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
    Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
    Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
    Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
    Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
    Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Decreased interleukin-17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice.
    Jiang JK; Lin CH; Chang TA; Lo LC; Lin CP; Lu RH; Yang CY
    Cancer Med; 2024 Mar; 13(5):e7059. PubMed ID: 38491831
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Canonical DDR activation by emt inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
    Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
    Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
    Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
    Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
    Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A prognostic marker LTBP1 is associated with epithelial mesenchymal transition and can promote the progression of gastric cancer.
    Jiang X; Yin S; Yin X; Wang Y; Fang T; Yang S; Bian X; Li G; Xue Y; Zhang L
    Funct Integr Genomics; 2024 Feb; 24(1):30. PubMed ID: 38358412
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Small extracellular vesicles promote the formation of the pre-metastatic niche through multiple mechanisms in colorectal cancer.
    Wu J; Wang X; Li Z; Yi X; Hu D; Wang Q; Zhong T
    Cell Cycle; 2024 Jan; 23(2):131-149. PubMed ID: 38341861
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote colorectal cancer Liver Metastasis.
    Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
    Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of Cichoric Acid on colorectal cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
    Ma S; Huang Z; Chen Q; Yin X
    Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
    Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
    Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
    Pastorino GA; Sheraj I; Huebner K; Ferrero G; Kunze P; Hartmann A; Hampel C; Husnugil HH; Maiuthed A; Gebhart F; Schlattmann F; Gulec Taskiran AE; Oral G; Palmisano R; Pardini B; Naccarati A; Erlenbach-Wuensch K; Banerjee S; Schneider-Stock R
    J Pathol; 2024 Mar; 262(3):347-361. PubMed ID: 38235615
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High MEIS3 Expression Indicates a Poor prognosis for Patients with Stage II/III colorectal cancer.
    Ma J; Li H; Gao Q; Zhang W; Zhu C; Chen J; Ling Y; Shao X; Li Z
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):338. PubMed ID: 38179750
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. H19: An Oncogenic Long Non-coding RNA in colorectal cancer.
    Chowdhury PR; Salvamani S; Gunasekaran B; Peng HB; Ulaganathan V
    Yale J Biol Med; 2023 Dec; 96(4):495-509. PubMed ID: 38161577
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anoikis regulator GLI2 promotes NC cell immunity escape by TGF-β-mediated non-classic hedgehog signaling in colorectal cancer: based on artificial intelligence and big data analysis.
    Shanshan Z; Fanfei D; Xuan S; Huina L; Ye Z; Jiayu L; Shuo Z; Xue P; Yingye P; Chengjun J; Hang P; Li L
    Aging (Albany NY); 2023 Dec; 15(24):14733-14748. PubMed ID: 38159250
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.